2023-504251-27-00
CTIS ↗
PC14586
Locally Advanced or Metastatic Solid Tumors Harboring a TP53 Y220C Mutation
pharma · Locally Advanced or Metastatic Solid Tumors Harboring a TP53 Y220C Mutation · Myelodysplastic Syndrome · PMVP
PMV Pharmaceuticals
PMV Pharmaceuticals trial registry — 8 ClinicalTrials.gov studies with program phase, status, and indication context.
PRINCETON, NJ, USA HQ
4 Employees
Public company Type
PMVP · NYSE Ticker
Company details
- Status
- Public
- HQ
- PRINCETON, NJ, USA
- Employees
- 4
- Programs
- 6
- Drugs
- 5
- Patents
- 11
PMV Pharmaceuticals clinical trials
Registry index of 8 ClinicalTrials.gov studies linked to PMV Pharmaceuticals programs — each row shows trial ID, program name, phase, status, and indication.
PMV Pharmaceuticals trial registry — 8 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for PMV Pharmaceuticals.
-
metformin hydrochloride 500 mg tablet — Phase 1
Clinical update -
PC14586 — Phase 2
Clinical update -
rezatapopt — Phase 2
Clinical update -
Azacitidine — Phase 1
Clinical update -
PC14586 — Phase 1
Clinical update -
[14C]-PC14586 — Phase 1
Clinical update -
Methods and compounds for restoring mutant p53 function
Patent grant -
Deuterated compounds for restoring mutant p53 function
Patent grant